American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

V42N6: Liver, Part III

Recommended Reading

Bhangui P, Allard MA, Vibert E, et al. Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes? Ann Surg. 2016;264(1):155-163

    This study reports data comparing outcomes of primary versus salvage liver transplantation for patients with early-stage hepatocellular carcinoma. The data analysis showed an advantage for primary transplantation.

Cameron AM. Screening for Viral Hepatitis and Hepatocellular Cancer. Surg Clin North Am. 2015;95(5):1013-1021.

    This is article is a thorough review of screening approaches for hepatitis and hepatocellular carcinoma.

El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118-1127.

    This article supplies a clearly written, detailed review of the pathophysiology, diagnosis and management of hepatocellular carcinoma.

Olthoff KM, Smith AR, Abecassis M, et al. Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg. 2015;262(3):465-475; discussion 473-465. Free Full Text

    Olthoff and coauthors provide an analysis of outcomes and patient selection criteria for living donor liver transplantation.

Rahbari NN, Mehrabi A, Mollberg NM, Muller SA, Koch M, Buchler MW, Weitz J. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg. 2011;253(3):453-469.

    This report provides perspective on the present and future management alternatives for hepatocellular carcinoma.

Ribero D, Zimmitti G, Aloia TA, et al. Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma. J Am Coll Surg. 2016;223(1):87-97.

    Ribero and coauthors provide data supporting an important association between preoperative cholangitis and liver remnant volume with outcomes of surgical resection of hilar cholangiocarcinoma.